Baxter International

Founded in 1931, Baxter International operates with its headquarters based in Deerfield, Illinois, United States. The company has carved out a leading position in various healthcare segments. Baxter International is a key provider in Renal Care, offering an array of products and services tailored for patients with kidney diseases, including hemodialysis and peritoneal dialysis options. The Medication Delivery segment delivers a significant contribution to the company with its intravenous (IV) solutions, administration sets, and infusion pumps. The Pharmaceuticals division is prominent in Baxter's portfolio, including premixed drugs, anesthetic gases, and sophisticated pharmacy automation solutions, while the Nutrition segment focuses on both parenteral and enteral feeding products as well as specialized nutritional formulations. Furthermore, Baxter International is at the forefront of Advanced Surgery, supplying hemostats and sealants that assist in a multitude of surgical procedures. The Acute Therapies division provides vital products for blood purification and treatments designed for individuals with acute kidney injury. Baxter International's most important brands are recognized for their contribution to healthcare; FLOSEAL, a hemostatic agent beneficial during surgery; GAMMAGARD, an immune globulin infusion therapy; Advate, a recombinant Anti-hemophilic Factor therapy; REPEL-CV, a bioresorbable cardiac adhesion barrier; TISSEEL, a fibrin sealant used in achieving hemostasis and sealing; and ACTIFUSE, which serves as a synthetic bone graft substitute. The company's products and services are sold in over 100 countries across the globe. Essential markets include the Americas, Europe, Asia, and Oceania, with the United States, countries in Western Europe, Japan, and Canada being particularly significant due to their developed healthcare systems. (Powered by AI)